Researchers at Children's Hospital of Philadelphia (CHOP) identified a potential new therapeutic target for eosinophilic ...

Fresenius Kabi, part of the global healthcare company Fresenius, and a leading provider of essential medicines and medical technologies, announced today it has introduced two new products in its ...

Bayer has started a phase 3 trial of its intrauterine contraceptive Mirena in an endometrial condition that can lead to ...

What Is Painful Intimate Discharges? Intimate activity is supposed to be enjoyable. So when you reach what you anticipate to ...

If approved, ReadyFlow Autoinjector would deliver an IV-equivalent diuretic dose (subcutaneous furosemide injection 80 mg/ml) ...

Frequent night-time urination may signal an enlarged prostate (BPH). Learn symptoms, when to see a doctor, and modern ...

Rome Health is expanding its robotic surgery program to provide men with a new minimally invasive option to treat an enlarged ...

Profound Medical (PROF) announced the upcoming launch of its TULSA-AI Volume Reduction module for optimizing the treatment of patients with benign ...

Profound Medical Corp. ("Profound" or the "Company"), a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ablation of diseased ...

The field of endothelial injury syndromes has undergone a significant transformation in recent decades. Initially perceived ...

Jyong Biotech advances plant-derived carotenoid drugs with MCS-2 for BPH and early programs like MCS-8 showing signals as ...